CiteIndex

Filter by Journals
ACS applied material ... (1)
Anti-cancer agents i ... (1)
BMC genomics (1)
Biomedicine & pharma ... (1)
Brain research bulle ... (1)
Cancers (1)
Carbohydrate polymers (2)
Complementary therap ... (1)
Current developments ... (1)
Dermatologic therapy (1)
EFSA journal. Europe ... (3)
Endocrinologia, diab ... (1)
Food chemistry (2)
Food science & nutri ... (1)
Gene expression patt ... (1)
International journa ... (2)
Journal of Applied B ... (1)
Journal of Applied P ... (1)
Journal of agricultu ... (1)
Journal of clinical ... (1)
Journal of diabetes ... (1)
Journal of food bioc ... (1)
Journal of medicinal ... (2)
Journal of natural m ... (2)
Journal of separatio ... (1)
Journal of the scien ... (1)
Journal of translati ... (1)
Medical mycology (1)
Molecular and cellul ... (1)
Molecules (Basel, Sw ... (4)
National Journal of ... (1)
Natural product rese ... (2)
Natural products and ... (1)
Nutrients (1)
Pharmacological rese ... (1)
Phytotherapy researc ... (1)
Plant foods for huma ... (1)
Plants (Basel, Switz ... (1)
PloS one (3)
Proceedings of the N ... (1)
Protoplasma (1)
Risk management and ... (1)
Scientific reports (2)
Stem cell research & ... (1)
Systematic Reviews i ... (1)
Systematic reviews (1)
The aging male : the ... (1)
Toxicological resear ... (1)
Turkish journal of c ... (1)
Veterinary world (1)


Filter by Years
2021 (16)
2020 (48)




Search Results for Momordica charantia
64 articles found.
1.
Metabolite Profile of Cucurbitane-Type Triterpenoids of Bitter Melon (Fruit of ) and Their Inhibitory Activity against Protein Tyrosine Phosphatases Relevant to Insulin Resistance.
Lee YH, Yoon SY, Baek J, Kim SJ, Yu JS, Kang H, Kang KS, Chung SJ, Kim KH.
Journal of agricultural and food chemistry. 2021; 69(6): 1816-1830
2.
Isolation, characterisation and investigation of antidiabetic and antioxidant activity of phytoconstituents from fruit of Linn.
Kulkarni P, Lohidasan S, Mahadik K.
Natural product research. 2021; 35(6): 1035-1037
3.
The safety and efficacy of Momordica charantia L. in animal models of type 2 diabetes mellitus: A systematic review and meta-analysis.
Peter EL, Nagendrappa PB, Kaligirwa A, Ogwang PE, Sesaazi CD.
Phytotherapy research : PTR. 2021; 35(2): 637-656
4.
Isolation, characterization and quantitative HPLC-DAD analysis of components of charantin from fruits of Momordica charantia.
Desai S, Tatke P, Mane T, Gabhe S.
Food chemistry. 2021; 345(): 128717
5.
Production, physicochemical characteristics, and in vitro biological activities of polysaccharides obtained from fresh bitter gourd (Momordica charantia L.) via room temperature extraction techniques.
Yan JK, Yu YB, Wang C, Cai WD, Wu LX, Yang Y, Zhang HN.
Food chemistry. 2021; 337(): 127798
6.
Anti-Inflammatory, Antidiabetic Properties and In Silico Modeling of Cucurbitane-Type Triterpene Glycosides from Fruits of an Indian Cultivar of L.
Perera WH, Shivanagoudra SR, Pérez JL, Kim DM, Sun Y, K Jayaprakasha G, S Patil B.
Molecules (Basel, Switzerland). 2021; 26(4):
7.
Suppressive Effect of Two Cucurbitane-Type Triterpenoids from on -Induced Inflammatory Responses in Human THP-1 Monocytic Cell and Mouse Models.
Chuang LT, Huang WC, Hou YC, Chyuan JH, Chang H, Chang CI, Tsai TH, Tsai PJ.
Molecules (Basel, Switzerland). 2021; 26(3):
8.
A phylogenetic analysis of Momordica (Cucurbitaceae) in India based on karyo-morphology, nuclear DNA content and rDNA ITS1-5.8S-ITS2 sequences.
Ghosh I, Saha PS, Bhowmick BK, Jha S.
Protoplasma. 2021; 258(2): 347-360
9.
Preparation, analysis, antioxidant activities in vivo of phosphorylated polysaccharide from Momordica charantia.
Chen F, Huang G, Huang H.
Carbohydrate polymers. 2021; 252(): 117179
10.
Development and validation of genome-wide InDel markers with high levels of polymorphism in bitter gourd (Momordica charantia).
Cui J, Peng J, Cheng J, Hu K.
BMC genomics. 2021; 22(1): 190
11.
Commodity risk assessment of fruits from Mexico.
, Bragard C, Dehnen-Schmutz K, Di Serio F, Gonthier P, Jacques MA, Jaques Miret JA, Justesen AF, MacLeod A, Magnusson CS, Navas-Cortes JA, Parnell S, Potting R, Reignault PL, Thulke HH, Van der Werf W, Vicent Civera A, Yuen J, Zappalà L, Lucchi A, Loomans A, Mosbach-Schulz O, de la Peña E, Milonas P.
EFSA journal. European Food Safety Authority. 2021; 19(2): e06398
12.
Commodity risk assessment of fruits from Sri Lanka.
, Bragard C, Dehnen-Schmutz K, Di Serio F, Gonthier P, Jacques MA, Jaques Miret JA, Justesen AF, MacLeod A, Magnusson CS, Navas-Cortes JA, Parnell S, Potting R, Reignault PL, Thulke HH, Van der Werf W, Vicent Civera A, Yuen J, Zappalà L, Lucchi A, Loomans A, Mosbach-Schulz O, de la Peña E, Milonas P.
EFSA journal. European Food Safety Authority. 2021; 19(2): e06397
13.
Commodity risk assessment of fruits from Honduras.
, Bragard C, Dehnen-Schmutz K, Di Serio F, Gonthier P, Jacques MA, Jaques Miret JA, Justesen AF, MacLeod A, Magnusson CS, Navas-Cortes JA, Parnell S, Potting R, Reignault PL, Thulke HH, Van der Werf W, Vicent Civera A, Yuen J, Zappalà L, Lucchi A, Loomans A, Mosbach-Schulz O, de la Peña E, Milonas P.
EFSA journal. European Food Safety Authority. 2021; 19(2): e06395
14.
Promotion of Momordica Charantia polysaccharides on neural stem cell proliferation by increasing SIRT1 activity after cerebral ischemia/reperfusion in rats.
Ma J, Fan H, Cai H, Hu Z, Zhou X, Li F, Chen H, Shen J, Qi S.
Brain research bulletin. 2021; 170(): 254-263
15.
Genetic analysis and QTL mapping of yield and fruit traits in bitter gourd (Momordica charantia L.).
Rao PG, Behera TK, Gaikwad AB, Munshi AD, Srivastava A, Boopalakrishnan G, Vinod .
Scientific reports. 2021; 11(1): 4109
16.
A Review of Its Effects on Metabolic Diseases and Mechanisms of Action.
Cortez-Navarrete M, Méndez-Del Villar M, Ramos-González EJ, Pérez-Rubio KG.
Journal of medicinal food. 2021; ():
17.
Effect of Cadmium-Tolerant Rhizobacteria on Growth Attributes and Chlorophyll Contents of Bitter Gourd under Cadmium Toxicity.
Zafar-Ul-Hye M, Naeem M, Danish S, Khan MJ, Fahad S, Datta R, Brtnicky M, Kintl A, Hussain GS, El-Esawi MA.
Plants (Basel, Switzerland). 2020; 9(10):
18.
Systematic review and meta-analysis protocol for efficacy and safety of Momordica charantia L. on animal models of type 2 diabetes mellitus.
Peter EL, Mtewa AG, Nagendrappa PB, Kaligirwa A, Sesaazi CD.
Systematic reviews. 2020; 9(1): 7
19.
Suppression of Inflammatory Cytokines Expression with Bitter Melon () in TNBS-instigated Ulcerative Colitis.
Semiz A, Ozgun Acar O, Cetin H, Semiz G, Sen A.
Journal of translational internal medicine. 2020; 8(3): 177-187
20.
Rapid in vitro adventitious rooting and proliferation by leaf and nodal cultures of Momordica cymbalaria Fenzl.
Chaitanya Gopu, Chandra Shekar Chakilam, Pavani Chirumamilla, Suvarchala Vankudoth, Shasthree Taduri.
Journal of Applied Biology & Biotechnology. 2020; 8(2): 103-107
21.
An antidiabetic nutraceutical combination of red yeast rice (), bitter gourd (), and chromium alleviates dedifferentiation of pancreatic β cells in db/db mice.
Lu KY, Chen SH, Lin YS, Wu HP, Chao PM.
Food science & nutrition. 2020; 8(12): 6718-6726
22.
Effects of Fermentation Conditions Using Lactobacillus plantarum on the Charantin, Stigmasterol Glucoside and β-sitosterol Glucoside Contents of Bitter Gourd (Momordica charantia L.) Juice.
Nguyen TTT, Nguyen HVH.
Plant foods for human nutrition (Dordrecht, Netherlands). 2020; 75(4): 656-658
23.
Correction to: Four new cucurbitane-type triterpenes from Momordica charantia L. with their cytotoxic activities and protective effects on HO-damaged pancreatic cells.
Yue J, Sun Y, Xu J, Zhang X, Zhao Y.
Journal of natural medicines. 2020; 74(1): 41
24.
Four new cucurbitane-type triterpenes from Momordica charantia L. with their cytotoxic activities and protective effects on HO-damaged pancreatic cells.
Yue J, Sun Y, Xu J, Zhang X, Zhao Y.
Journal of natural medicines. 2020; 74(1): 34-40
25.
Possible adaptogenic effects of on high-intensity training-induced alteration in the hypothalamic-pituitary-adrenal axis.
Yook JS, Kwak JJ, Jeong WM, Song YH, Hijioka Y, Honda Y, Kim SE, Ha MS.
Journal of clinical biochemistry and nutrition. 2020; 67(3): 290-296
26.
Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
Kim SK, Jung J, Jung JH, Yoon N, Kang SS, Roh GS, Hahm JR.
Complementary therapies in medicine. 2020; 52(): 102524
27.
Purification and biochemical characterization of a novel secretory dipeptidyl peptidase IV from porcine serum.
Kumar D, Hamse VK, Neema KN, Babu Shubha P, Chetan DM, Shivananju NS.
Molecular and cellular biochemistry. 2020; 471(1-2): 71-80
28.
Protein extracts from Momordica charantia var. charantia and M. charantia var. muricata show anti-lipidemic and antioxidant properties in experimental type 2 diabetic rats.
Poovitha S, Parani M.
Journal of food biochemistry. 2020; 44(9): e13370
29.
Comparison of antioxidant capacities and antioxidant components of commercial bitter melon (Momordica charantia L.) products.
AkyÜz E, TÜrkoĞlu S, SÖzgen BaŞkan K, TÜtem E, Apak MR.
Turkish journal of chemistry. 2020; 44(6): 1663-1673
30.
A simple, cost-effective, and rapid separation process for the isolation of anticoagulant active fraction from the fruit extract of Momordica charantia: Characterization of bioactive components and anticoagulant mechanism of active fraction in a mouse model.
Gogoi D, Jha S, Chattopadhyay P, Mukherjee AK.
Journal of separation science. 2020; 43(20): 3902-3912
31.
De novo assembly and Transcriptome Analysis of the Momordica charantia Seedlings Responding to methyl jasmonate using 454 pyrosequencing.
Yi S, Song X, Yu W, Zhang R, Wang W, Zhao Y, Han B, Gai Y.
Gene expression patterns : GEP. 2020; 40(): 119160
32.
Bitter Melon ( L.) Supplementation Has No Effect on Hypercholesterolemia and Atherosclerosis in Mice.
Mohammadmoradi S, Howatt DA, Lu HS, Daugherty A, Saha SP.
Current developments in nutrition. 2020; 4(10): nzaa148
33.
mitigates hepatic injury following adjuvant treatment with antiretroviral drugs in diabetic animal models.
Offor U, Naidu ECS, Ogedengbe OO, Aniekan PI, Azu OO.
Toxicological research. 2020; 36(1): 37-44
34.
Role of Momordica charantia in preventing the natural aging process of skin and sexual organs in mice.
Hiramoto K, Orita K, Yamate Y, Kobayashi H.
Dermatologic therapy. 2020; 33(6): e14243
35.
Extract Protects against Diabetes-Related Spermatogenic Dysfunction in Male Rats: Molecular and Biochemical Study.
Soliman GA, Abdel-Rahman RF, Ogaly HA, Althurwi HN, Abd-Elsalam RM, Albaqami FF, Abdel-Kader MS.
Molecules (Basel, Switzerland). 2020; 25(22):
36.
Effects of Storage Time and Temperature on Antioxidants in Juice from L. and L. var. Ser.
Lin YS, Huang WY, Ho PY, Hu SY, Lin YY, Chen CY, Chang MY, Huang SL.
Molecules (Basel, Switzerland). 2020; 25(16):
37.
Cold plasma treated phlorotannin/Momordica charantia polysaccharide nanofiber for active food packaging.
Cui H, Yang X, Abdel-Samie MA, Lin L.
Carbohydrate polymers. 2020; 239(): 116214
38.
Anti-Inflammatory Effect of Crude Extract on 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Colitis Model in Rat and the Bioaccessibility of its Carotenoid Content.
Ünal NG, Kozak A, Karakaya S, Oruç N, Barutçuoğlu B, Aktan Ç, Sezak M, Özütemiz AÖ.
Journal of medicinal food. 2020; 23(6): 641-648
39.
The Effect of Bitter Melon (Momordica charantia) Extract on the Uptake of 99mTc Labeled Paclitaxel: In Vitro Monitoring in Breast Cancer Cells.
Kilcar AY, Yildiz O, Dogan T, Sulu E, Takan G, Muftuler FZB.
Anti-cancer agents in medicinal chemistry. 2020; 20(12): 1497-1503
40.
Mormodica charantia L. fruit and Genistein ameliorates type 2 diabetes in rats by preventing lipid accumulation, insulin resistance and enhancing beta cell function.
Makena W, Hambolu JO, Timbuak JA, Umana UE, Iliya AI, Dibal NI.
Journal of diabetes and metabolic disorders. 2020; 19(2): 1303-1310
41.
MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
Chan DW, Yung MM, Chan YS, Xuan Y, Yang H, Xu D, Zhan JB, Chan KK, Ng TB, Ngan HY.
Pharmacological research. 2020; 161(): 105157
42.
Synthesis of selenylated polysaccharides from Momordica charantia L. and its hypoglycemic activity in streptozotocin-induced diabetic mice.
Ru Y, Liu K, Kong X, Li X, Shi X, Chen H.
International journal of biological macromolecules. 2020; 152(): 295-304
43.
Comparison of biogenic silver nanoparticles formed by Momordica charantia and Psidium guajava leaf extract and antifungal evaluation.
Nguyen DH, Vo TNN, Nguyen NT, Ching YC, Hoang Thi TT.
PloS one. 2020; 15(9): e0239360
44.
Red elemental selenium nanoparticles mediated substantial variations in growth, tissue differentiation, metabolism, gene transcription, epigenetic cytosine DNA methylation, and callogenesis in bittermelon (Momordica charantia); an in vitro experiment.
Rajaee Behbahani S, Iranbakhsh A, Ebadi M, Majd A, Ardebili ZO.
PloS one. 2020; 15(7): e0235556
45.
Gene expression and metabolic changes of Momordica charantia L. seedlings in response to low temperature stress.
Niu Y, Liu Z, He H, Han X, Qi Z, Yang Y.
PloS one. 2020; 15(5): e0233130
46.
Impregnation of magnetic - Momordica charantia leaf powder into chitosan for the removal of U(VI) from aqueous and polluted wastewater.
Yuvaraja G, Su M, Chen DY, Pang Y, Kong LJ, Subbaiah MV, Wen JC, Reddy GM.
International journal of biological macromolecules. 2020; 149(): 127-139
47.
The gut microbiota confers the lipid-lowering effect of bitter melon (Momordica charantia L.) In high-fat diet (HFD)-Induced hyperlipidemic mice.
Zhang F, Zhang X, Yu J, Tan Y, Guo P, Wu C.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2020; 131(): 110667
48.
Methanol leaf extract of protects alloxan-induced hepatopathy through modulation of caspase-9 and interleukin-1β signaling pathways in rats.
Ofuegbe SO, Oyagbemi AA, Omobowale TO, Adedapo AD, Ayodele AE, Yakubu MA, Oguntibeju OO, Adedapo AA.
Veterinary world. 2020; 13(8): 1528-1535
49.
Exploring the Factors Affecting Bitter Melon Peptide Intake Behavior: A Health Belief Model Perspective.
Pan F, Hsu PK, Chang WH.
Risk management and healthcare policy. 2020; 13(): 2219-2226
50.
Bitter Melon (), a Nutraceutical Approach for Cancer Prevention and Therapy.
Sur S, Ray RB.
Cancers. 2020; 12(8):
51.
mcIRBP-19 of Bitter Melon Peptide Effectively Regulates Diabetes Mellitus (DM) Patients' Blood Sugar Levels.
Hsu PK, Pan FFC, Hsieh CS.
Nutrients. 2020; 12(5):
52.
Sacrifice Template Strategy to the Fabrication of a Self-Cleaning Nanofibrous Membrane for Efficient Crude Oil-in-Water Emulsion Separation with High Flux.
Wu M, Liu W, Mu P, Wang Q, Li J.
ACS applied materials & interfaces. 2020; 12(47): 53484-53493
53.
Long-read bitter gourd () genome and the genomic architecture of nonclassic domestication.
Matsumura H, Hsiao MC, Lin YP, Toyoda A, Taniai N, Tarora K, Urasaki N, Anand SS, Dhillon NPS, Schafleitner R, Lee CR.
Proceedings of the National Academy of Sciences of the United States of America. 2020; 117(25): 14543-14551
54.
Acute and Subchronic Toxicity of Momordica Charantia L Fruits Ethanolic Extract in Liver and Kidney
Syamsudin Abdillah, Bilqis Inayah, Kartiningsih, Anggita Balqis Febrianti, and Safira Nafisa.
Systematic Reviews in Pharmacy. 2020; 11(12): 2249-2255
55.
Momordica charantia polysaccharides modulate the differentiation of neural stem cells via SIRT1/Β-catenin axis in cerebral ischemia/reperfusion.
Hu Z, Li F, Zhou X, Zhang F, Huang L, Gu B, Shen J, Qi S.
Stem cell research & therapy. 2020; 11(1): 485
56.
Momordica charantia improves biochemical indices in alloxan-induced diabetic rat model
Olusoji Adebusoye Oyesola, Philemon H-D Shallie, Ifabunmi Oduyemi Osonuga, Olaniyi Azeez Soetan, Ifedolapo Ibukunoluwa-Gloria Owoeye.
National Journal of Physiology, Pharmacy and Pharmacology. 2020; 10(9): 788-794
57.
Optimization of pancreatic islet isolation from rat and evaluation of islet protective potential of a saponin isolated from fruits of Momordica dioica
Suman Samaddar, Deepak K. Jha, Raju Koneri.
Journal of Applied Pharmaceutical Science. 2020; 10(7): 89-99
58.
Cucurbitane-Type Triterpene Glycosides from Momordica charantia and Their α-Glucosidase Inhibitory Activities.
Gao Y, Chen JC, Peng XR, Li ZR, Su HG, Qiu MH.
Natural products and bioprospecting. 2020; 10(3): 153-161
59.
Structural characterization and in-silico analysis of Momordica charantia 7S globulin for stability and ACE inhibition.
Kesari P, Pratap S, Dhankhar P, Dalal V, Mishra M, Singh PK, Chauhan H, Kumar P.
Scientific reports. 2020; 10(1): 1160
60.
Effect of Momordica saponin- and Cyclocarya paliurus polysaccharide-enriched beverages on oxidative stress and fat accumulation in Caenorhabditis elegans.
Lin C, Lin Y, Xiao J, Lan Y, Cao Y, Chen Y.
Journal of the science of food and agriculture. 2020; ():
61.
Saponins of Momordica charantia increase insulin secretion in INS-1 pancreatic β-cells via the PI3K/Akt/FoxO1 signaling pathway.
Liu Y, Mu S, Chen W, Liu S, Cong Y, Liu J, Jia N.
Endocrinologia, diabetes y nutricion. 2020; ():
62.
Antifungal resistance-modifying multiplexing action of Momordica charantia protein and phosphorylated derivatives on the basis of growth-dependent gene coregulation in Candida albicans.
Yuan-Biao Q, Lan-Fang Z, Qi Q, Jia-Hui N, Ze-Mei R, Hai-Mei Y, Chen-Chen Z, Hong-Ju P, Nan-Nan D, Qing-Shan L.
Medical mycology. 2020; ():
63.
Can the biological mechanisms of ageing be corrected by food supplementation. The concept of health care over sick care.
Comhaire F, Decleer W.
The aging male : the official journal of the International Society for the Study of the Aging Male. 2020; (): 1-12
64.
NMR-based metabolomic profiling of the differential concentration of phytomedicinal compounds in pericarp, skin and seeds of (bitter melon).
Mishra S, Ankit , Sharma R, Gogna N, Dorai K.
Natural product research. 2020; (): 1-6

P A G E S

Home
Journals
Keywords

P A R T N E R S

ScopeMed
BiblioMed
eJManager

Privacy Policy | citeindex.org © 2021